Skip to main content

Animations

MJFF Publications

3741 - 3750 of 6560 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2018
  • 2023
  • 2023
  • 2023
  • 2022
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-191590
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-019-09835-4
    Citation Count: 111
  • Summary Details
    OPEN
    Title: The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27614
    Citation Count: 94
  • Summary Details
    OPEN
    Title: Early detection of Parkinson’s disease through patient questionnaire and predictive modelling
    Journal Name: International Journal of Medical Informatics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ijmedinf.2018.09.008
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2023.2338
    Citation Count: 45
  • Summary Details
    OPEN
    Title: American Football Play and Parkinson Disease Among Men
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2023.28644
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Is REM Sleep Behavior Disorder Changing? Secular Changes Versus Referral Patterns
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mdc3.13842
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Structural and biochemical insights into lipid transport by VPS13 proteins
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1083/jcb.202202030
    Citation Count: 82
  • Summary Details
    OPEN
    Title: Toward a standard model for autophagosome biogenesis
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1083/jcb.202304011
    Citation Count: 23
  • Summary Details
    OPEN
    Title: A cholinergic contribution to postural control and freezing of gait in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad223
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.